Table 2.
Baseline comorbidities of the patients
| Total | Non-squamous | Squamous | p-value | |
|---|---|---|---|---|
| Comorbidities | < 0,001 | |||
| None | 1.530 (17,4%) | 1.334 (18,7%) | 196 (11,7%) | |
| At least one | 7.266 (82,6%) | 5.785 (81,3%) | 1.481 (88,3%) | |
| Hypertension (HT) | 3.704 (42,1%) | 2.904 (40,8%) | 800 (47,7%) | < 0,001 |
| Dyslipidemia | 2.499 (28,4%) | 1.992 (28,0%) | 507 (30,2%) | 0,066 |
| Diabetes Mellitus (DM) | 1.652 (18,8%) | 1.242 (17,4%) | 410 (24,4%) | < 0,001 |
| Chronic Obstructive Pulmonary Disease (COPD) | 1.588 (18,1%) | 1.092 (15,3%) | 496 (29,6%) | < 0,001 |
| Cardiomyopathy | 1.293 (14,7%) | 960 (13,5%) | 333 (19,9%) | < 0,001 |
| Depression/Anxiety | 642 (7,3%) | 543 (7,6%) | 99 (5,9%) | 0,014 |
| Former Alcoholism | 635 (7,2%) | 493 (6,9%) | 142 (8,5%) | 0,031 |
| Hypercholesterolemia | 619 (7,0%) | 498 (7,0%) | 121 (7,2%) | 0,750 |
| Vasculopathy | 481 (5,5%) | 366 (5,1%) | 115 (6,9%) | 0,007 |
| Obesity | 333 (3,8%) | 259 (3,6%) | 74 (4,4%) | 0,136 |
| Nephropathy | 236 (2,7%) | 179 (2,5%) | 57 (3,4%) | 0,053 |
| Hepatitis | 177 (2,0%) | 140 (2,0%) | 37 (2,2%) | 0,500 |
| Asthma | 171 (1,9%) | 145 (2,0%) | 26 (1,6%) | 0,237 |
| Tuberculosis | 137 (1,6%) | 110 (1,5%) | 27 (1,6%) | 0,827 |
| Other | 3.881 (44,1%) | 3065 (43,1%) | 816 (48,7%) | < 0,001 |